Biora Therapeutics Inc (BIOR) Financials

$0.69

$0.00 (0.01%)

As on 08-Jul-2022 09:30EDT

Market cap

$163 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	1.00	1.25	74.31	143.99	127.97	--
Cost of Revenue	--	--	93.43	100.49	92.08	--
Gross Profit	1.00	1.25	-19.12	43.49	35.90	--
Operating Expenses	68.76	119.08	176.07	183.61	150.14	--
Operating Profit (EBIT)	-84.84	-117.84	-195.19	-140.12	-114.24	--
Other Income	-42.45	-48.17	-24.89	--	--	--
Profit before Tax	-126.30	-178.64	-230.06	-148.74	-123.86	--
Provision for Tax	-0.96	-0.12	-37.53	-0.71	5.25	--
Profit after Tax (Net Income)	-155.94	-247.41	-192.53	-148.04	-129.11	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-155.94	-247.41	-192.80	-228.83	-129.11	--

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	-96.11	-84.98	-106.99	-83.87	-36.97	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	132.62	132.21	188.76	85.26	75.31	--
Current Liabilities	40.58	61.61	72.67	100.34	78.06	--
Total Liabilities	117.69	108.84	154.44	101.73	116.40	--

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	16.96	10.41	28.10	27.08	27.45	--
Current Assets	60.15	98.43	126.34	74.65	88.95	--
Total Assets	137.25	108.84	154.44	101.73	116.40	--
Total Debt*	--	--	177.84	72.65	71.74	--
Net Current Assets	--	36.82	53.67	-25.69	10.89	--

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-167.49	-165.74	-106.12	-65.13	--
Cash Flow from Investing Activities	--	-1.24	-4.94	16.53	55.83	--
Cash from Financing Activities	--	166.83	229.72	73.64	-12.81	--
Net Cash Inflow / Outflow	--	-3.68	59.03	--	--	--

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	--	-1.49	-3.91	-4.22	--	--
Cash EPS ($)	--	-1.48	-3.80	-4.04	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.01	-3.36	-3.03	--	--
Free Cash Flow per Share ($)	--	-1.01	-3.46	-3.13	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	3,501.69	-645.88	-1,257.59	--	--
ROE (%)	--	257.76	201.74	245.01	--	--
ROA (%)	-90.97	-187.95	-150.31	-135.74	--	--
EBIT Margin (%)	-15,251.46	-18,836.81	-262.66	-96.92	-89.68	--
Net Margin (%)	376.16	527.31	-389.54	-102.81	-100.88	--
Cash Profit Margin (%)	-0.02	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	-98.47	-0.98	-0.48	0.13	--	--
EBIT Growth (%)	24.02	-20.34	-39.88	-21.59	--	--
Net Profit Growth (%)	33.19	-28.51	-30.05	-14.66	--	--
EPS Growth (%)	--	0.62	0.07	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	-1.40	-1.36	--	--	--
Price / Book Value	--	-4.08	-2.45	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	-1.11	-1.83	--	--	--
Close Price ($)	0.70	2.09	5.31	--	--	--
High Price ($)	6.20	7.86	15.92	--	--	--
Low Price ($)	0.56	0.66	3.08	--	--	--
Market Cap ($ Cr)	162.92	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	-1.32	--	-1.66	-0.87	-1.94	--
Short term debt to equity ratio	-0.06	-0.22	-0.01	0.00	-0.01	--
Current Ratio	1.48	1.60	1.74	0.74	1.14	--
Quick Ratio	1.48	--	1.57	0.63	1.04	--
Interest Coverage	-10.33	--	--	--	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	82.11	52.37	17.07	15.85	6.37	--
Asset Turnover	0.01	0.01	0.58	1.32	--	--
Receivable days	--	1,952.93	87.25	39.28	23.25	--
Inventory Days	--	--	45.26	33.72	30.21	--
Payable days	--	--	64.82	48.68	43.77	--
Cash Conversion Cycle	--	--	67.69	24.31	9.69	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.